[Long-term use of ethacizin in outpatients with ventricular disorders of heart rhythm].
Therapeutic efficacy and tolerance to long-term (2 years and longer) ambulatory administration of the new drug--ethacixin--was studied in 48 patients with various ventricular rhythm disturbances. Long-term administration of 150-200 mg of the drug daily produced a preventive effect in all those patients with ventricular rhythm disturbances, in whom it was effective during 4-7-day therapy. Ethacizin had to be discontinued in only 2 out of 48 patients because of considerable side effects.
D000328:Adult; D000553:Ambulatory Care; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D004341:Drug Evaluation; D004361:Drug Tolerance; D004562:Electrocardiography; D006801:Humans; D008875:Middle Aged; D016293:Moricizine / Q000031:analogs & derivatives*; D010640:Phenothiazines / Q000009:adverse effects / Q000627:therapeutic use*; D013610:Tachycardia / Q000188:drug therapy; D013997:Time Factors
D000889:Anti-Arrhythmia Agents; D010640:Phenothiazines; C027240:diethylamino-ethmozine; D016293:Moricizine
Dlitel'noe primenenie étatsizina v ambulatornykh usloviiakh u bol'nykh s zheludochkovymi narusheniiami ritma serdtsa.